Holen Sie sich die Stockscreener-App
559.65
0.91%
-5.16
Handel nachbörslich:
557.00
-2.65
-0.47%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$564.81
Offen:
$566.14
24-Stunden-Volumen:
504.97K
Relative Volume:
1.07
Marktkapitalisierung:
$24.53B
Einnahmen:
$3.18B
Nettoeinkommen (Verlust:
$1.33B
KGV:
20.06
EPS:
27.9001
Netto-Cashflow:
$1.04B
1W Leistung:
-4.88%
1M Leistung:
+17.04%
6M Leistung:
+23.47%
1J Leistung:
+91.36%
1-Tages-Spanne:
$552.54
$567.38
1-Wochen-Bereich:
$551.30
$599.00
52-Wochen-Spanne:
$266.98
$607.89
United Therapeutics Corp Stock (UTHR) Company Profile
Firmenname
United Therapeutics Corp
Sektor
Telefon
(301) 608-9292
Adresse
1000 SPRING ST, SILVER SPRING, MD
Compare UTHR vs TAK, ZTS, HLN, TEVA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
559.65 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.26 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.92 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.82 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Underweight |
| 2025-09-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-06-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | Hochstufung | Goldman | Sell → Neutral |
| 2024-02-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-06 | Eingeleitet | UBS | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Sell |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-20 | Bestätigt | BofA Securities | Underperform |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-02-11 | Eingeleitet | BTIG Research | Neutral |
| 2021-07-14 | Hochstufung | Argus | Hold → Buy |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-02-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-06-25 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-03-10 | Hochstufung | Jefferies | Hold → Buy |
| 2020-02-27 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-01-31 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-03 | Eingeleitet | BofA/Merrill | Underperform |
| 2019-08-01 | Hochstufung | Jefferies | Underperform → Hold |
| 2019-08-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-09 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | Hochstufung | Standpoint Research | Hold → Buy |
| 2018-08-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Barclays | Underweight |
| 2018-01-18 | Fortgesetzt | Credit Suisse | Underperform |
| 2017-12-27 | Bestätigt | Wedbush | Outperform |
| 2017-04-27 | Bestätigt | Wedbush | Outperform |
| 2017-03-30 | Eingeleitet | UBS | Sell |
| 2017-03-16 | Eingeleitet | Credit Suisse | Underperform |
Alle ansehen
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
Perpetual Ltd Makes New Investment in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation (UTHR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Element Squared LLC Acquires New Position in United Therapeutics Corporation $UTHR - MarketBeat
Will United Therapeutics (UTHR) Surpass Expectations in Its Upcoming Earnings Announcement? - Bitget
United Therapeutics' Strong Competitive Edge and Robust Cash Flow Indicate a Sustainable Value Opportunity - Bitget
Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,610,605.00 in Stock - MarketBeat
UNITED THERAPEUTICS CORP (UTHR.MX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Allspring Global Investments Holdings LLC Has $52.05 Million Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
UTHR Stock Price, Quote & Chart | UNITED THERAPEUTICS CORP (NASDAQ:UTHR) - ChartMill
United Therapeutics: Maintaining 'Strong Buy' On Second TETON Study Program Win (UTHR) - Seeking Alpha
United Therapeutics Corp at TD Cowen Healthcare Conference Transcript - gurufocus.com
BKMC Volume Surges 38-Fold as United Therapeutics Jumps - tipranks.com
United Therapeutics (UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan
United Therapeutics (NASDAQ: UTHR) CFO exercises options and sells 10k shares - Stock Titan
UNITED THERAPEUTICS (UTHR) director exercises options and sells 1,300 shares under 10b5-1 plan - Stock Titan
UNITED THERAPEUTICS (UTHR) CEO sells 9,500 shares after option exercise - Stock Titan
United Therapeutics Corporation (UTHR) Stock forecasts - Yahoo Finance UK
Wells Fargo Raises Price Target for United Therapeutics (UTHR) t - gurufocus.com
United Therapeutics (NASDAQ:UTHR) Price Target Raised to $660.00 at HC Wainwright - MarketBeat
United Therapeutics (UTHR): Analyst Greg Harrison Raises Price T - gurufocus.com
United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo - 24/7 Wall St.
Retirement Systems of Alabama Has $47.39 Million Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (UTHR) Moves 12.5% Higher: Will This Strength Last? - Yahoo Finance
United Therapeutics Corp (UTHR) Stock Price Up 13.08% on Mar 30 - gurufocus.com
United Therapeutics (UTHR) Achieves Key Milestone in IPF Treatme - gurufocus.com
United Therapeutics (UTHR) Sees Positive Results in TETON-1 Stud - gurufocus.com
United Therapeutics (UTHR) Tyvaso Shows Promising Results in TET - GuruFocus
United Therapeutics stock surges 32% in 6 months: Here's why - MSN
United Therapeutics (UTHR) Stock Surges Over 12% - gurufocus.com
United Therapeutics (UTHR) Surges Nearly 12% - gurufocus.com
Why United Therapeutics (UTHR) Stock Is Up Today - Yahoo Finance
UTHR: TD Cowen Raises United Therapeutics Price Target to $660 | - gurufocus.com
United Therapeutics Announces Successful Tyvaso Trial - National Today
United Therapeutics (NASDAQ: UTHR) proposed sale of 1,300 shares via option - Stock Titan
United Therapeutics Stock Surges Due to Positive Phase 3 Trial Results - timothysykes.com
United Therapeutics Corp (UTHR) Stock Price Quote Today & Current Price Chart - Capital.com
United Therapeutics Rises on Positive Study for Cornerstone Drug. Why Shares Could Run Even Higher. - Barron's
U.S. Indexes Ended Monday Mixed As United Therapeutics Led, Sysco Lagged - Barron's
United Therapeutics Surges Amid Successful Phase 3 Trials - timothysykes.com
Ralinepag Clinical Trials Propel United Therapeutics Stock Soaring - StocksToTrade
Stocks Rise As Powell's Remarks Cool Rate Fears: What's Moving Markets Monday? - Benzinga
United Therapeutics’ Nebulized Tyvaso Achieves Primary Endpoint in TETON-1 Study for Idiopathic Pulmonary Fibrosis, Outperforming Placebo and TETON-2 Results 12 - Minichart
United’s Tyvaso nails endpoints in second phase III IPF trial - BioWorld MedTech
Jefferies raises United Therapeutics stock price target on IPF data By Investing.com - Investing.com India
BofA raises United Therapeutics stock price target on trial data By Investing.com - Investing.com Australia
BofA raises United Therapeutics stock price target on trial data - investing.com
Jefferies raises United Therapeutics stock price target on trial data By Investing.com - Investing.com Australia
United Therapeutics shares surge after positive IPF trial results - Yahoo! Finance Canada
Jefferies raises United Therapeutics stock price target on IPF data - investing.com
Jefferies raises United Therapeutics stock price target on trial data - investing.com
United Therapeutics jumps 14.9% as investors refocus on big buyback and positive ralinepag Phase 3 readout - Quiver Quantitative
Finanzdaten der United Therapeutics Corp-Aktie (UTHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
United Therapeutics Corp-Aktie (UTHR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MAHON PAUL A | EVP & GENERAL COUNSEL |
Apr 02 '26 |
Sale |
565.87 |
8,300 |
4,696,690 |
45,172 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Apr 01 '26 |
Option Exercise |
146.03 |
9,500 |
1,387,285 |
50,013 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Apr 01 '26 |
Sale |
581.63 |
9,500 |
5,525,526 |
40,513 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Mar 31 '26 |
Option Exercise |
146.03 |
9,500 |
1,387,285 |
50,013 |
| ROTHBLATT MARTINE A | Chairperson & CEO |
Mar 31 '26 |
Sale |
585.76 |
9,500 |
5,564,709 |
40,513 |
0.22%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):